Vasopressin and V2 Receptor in Meniere's Disease
NCT00599560 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135
Last updated 2016-03-29
Summary
Summary: Some of sicknesses are well known to be provoked by inadequate adaptation to physical and/or psychogenic stress in their daily life. Meniere's disease is also a common inner ear disease accompanied with vertigo, hearing loss and tinnitus especially in civilized people under stressed life style. Its oto-pathology was firstly revealed in 1938 to be inner ear endolymphatic hydrops through the temporal bone study. To elucidate the neuroscientific relationship between "stress" and "inner ear", we examined plasma vasopressin (the anti-diuretic "stress" hormone) and its receptor, V2R in the endolymphatic sac (the "inner ear" endo-organ for endolymph absorption) in Meniere's patients.
Conditions
- Meniere Disease
Interventions
- GENETIC
-
vasopressin, V2 receptor and cyclic AMP
plasma vasopressin, V2 receptor, cyclic AMP
Sponsors & Collaborators
-
Osaka City University
collaborator OTHER -
Osaka University
lead OTHER
Principal Investigators
-
Tadashi Kitahara, M.D.,Ph.D. · Department of ORL, Osaka University, School of Medicine
-
Hiroshi Kiyama, Ph.D. · Department of Neuroanatomy, Osaka City University, School of Medicine
-
Takeshi Kubo, M.D.,Ph.D. · Department of ORL, Osaka University, School of Medicine
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-04-30
- Primary Completion
- 2005-09-30
- Completion
- 2005-09-30
Countries
- Japan
Study Locations
More Related Trials
-
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
NCT04218123 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
OTO-104 for the Treatment of Meniere's Disease
NCT01412177 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Meniere's Disease With Migraine Medications
NCT05582837 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Endolymphatic Sac Drainage With Steroids for Meniere's Disease
NCT00500474 ·Status: COMPLETED ·Phase: NA
-
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
NCT04674735 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02612337 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Acamprosate for Tinnitus
NCT00596531 ·Status: COMPLETED ·Phase: PHASE1
-
Tinnitus Measured by MEG and Synchronous Neural Interaction™ Test: Template Development
NCT01185990 ·Status: UNKNOWN
-
The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial
NCT05650645 ·Status: COMPLETED ·Phase: PHASE2
-
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508 ·Status: RECRUITING ·Phase: PHASE3
-
Minimally Invasive Vestibular Neurectomy Versus Tenotomy of the Stapedius and Tensor Tympani Muscles in the Management of Patients With Unilateral Meniere's Disease
NCT04847700 ·Status: UNKNOWN ·Phase: NA
-
Ménière's Disease Registry
NCT04438538 ·Status: COMPLETED
-
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
NCT04815187 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Sleep Disorders and Their Impact on Patients With Ménière's Disease
NCT07299578 ·Status: RECRUITING
-
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
NCT06001593 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
NCT06765993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy of Antiviral Medications in Controlling Vertigo Attacks of Patients With Meniere's Disease
NCT01729767 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
NCT06278129 ·Status: RECRUITING
-
Ventilation Tube Insertion for Unilateral Menière's Disease
NCT04835688 ·Status: UNKNOWN ·Phase: NA
-
Study of EEG and Nasal Stimulus in Olfactory Disorders
NCT06589375 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02706730 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT03664674 ·Status: COMPLETED ·Phase: PHASE3
-
Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
NCT00802529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Laser Acupuncture for Meniere Disease
NCT06544434 ·Status: RECRUITING ·Phase: PHASE2